These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 37742293

  • 21. SPAG5-AS1 inhibited autophagy and aggravated apoptosis of podocytes via SPAG5/AKT/mTOR pathway.
    Xu J, Deng Y, Wang Y, Sun X, Chen S, Fu G.
    Cell Prolif; 2020 Feb; 53(2):e12738. PubMed ID: 31957155
    [Abstract] [Full Text] [Related]

  • 22. Compromised glycolysis contributes to foot process fusion of podocytes in diabetic kidney disease: Role of ornithine catabolism.
    Luo Q, Liang W, Zhang Z, Zhu Z, Chen Z, Hu J, Yang K, Chi Q, Ding G.
    Metabolism; 2022 Sep; 134():155245. PubMed ID: 35780908
    [Abstract] [Full Text] [Related]

  • 23. Podocyte Autophagy: A Potential Therapeutic Target to Prevent the Progression of Diabetic Nephropathy.
    Liu N, Xu L, Shi Y, Zhuang S.
    J Diabetes Res; 2017 Sep; 2017():3560238. PubMed ID: 28512641
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Wogonin protects glomerular podocytes by targeting Bcl-2-mediated autophagy and apoptosis in diabetic kidney disease.
    Liu XQ, Jiang L, Li YY, Huang YB, Hu XR, Zhu W, Wang X, Wu YG, Meng XM, Qi XM.
    Acta Pharmacol Sin; 2022 Jan; 43(1):96-110. PubMed ID: 34253875
    [Abstract] [Full Text] [Related]

  • 27. Curcumin alleviates diabetic nephropathy via inhibiting podocyte mesenchymal transdifferentiation and inducing autophagy in rats and MPC5 cells.
    Tu Q, Li Y, Jin J, Jiang X, Ren Y, He Q.
    Pharm Biol; 2019 Dec; 57(1):778-786. PubMed ID: 31741405
    [Abstract] [Full Text] [Related]

  • 28. miR-1187 induces podocyte injury and diabetic nephropathy through autophagy.
    Chen B, He Q.
    Diab Vasc Dis Res; 2023 Dec; 20(3):14791641231172139. PubMed ID: 37208852
    [Abstract] [Full Text] [Related]

  • 29. Notoginsenoside R1 attenuates glucose-induced podocyte injury via the inhibition of apoptosis and the activation of autophagy through the PI3K/Akt/mTOR signaling pathway.
    Huang G, Zou B, Lv J, Li T, Huai G, Xiang S, Lu S, Luo H, Zhang Y, Jin Y, Wang Y.
    Int J Mol Med; 2017 Mar; 39(3):559-568. PubMed ID: 28112381
    [Abstract] [Full Text] [Related]

  • 30. Renoprotective Effect of Isoorientin in Diabetic Nephropathy via Activating Autophagy and Inhibiting the PI3K-AKT-TSC2-mTOR Pathway.
    Kong Z, Xiao M, Wang B, Zhang W, Che K, Lv W, Wang Y, Huang Y, Zhao H, Zhao Y, Qi M, Chi J, Wang Y.
    Am J Chin Med; 2023 Mar; 51(5):1269-1291. PubMed ID: 37335208
    [Abstract] [Full Text] [Related]

  • 31. TangShenWeiNing Formula Prevents Diabetic Nephropathy by Protecting Podocytes Through the SIRT1/HIF-1α Pathway.
    Chang J, Zheng J, Gao X, Dong H, Yu H, Huang M, Sun Z, Feng X.
    Front Endocrinol (Lausanne); 2022 Mar; 13():888611. PubMed ID: 35721758
    [Abstract] [Full Text] [Related]

  • 32. Krüppel‑like factor 4 ameliorates diabetic kidney disease by activating autophagy via the mTOR pathway.
    Gong J, Zhan H, Li Y, Zhang W, Jin J, He Q.
    Mol Med Rep; 2019 Oct; 20(4):3240-3248. PubMed ID: 31432191
    [Abstract] [Full Text] [Related]

  • 33. Protective effect of the tunneling nanotube-TNFAIP2/M-sec system on podocyte autophagy in diabetic nephropathy.
    Barutta F, Bellini S, Kimura S, Hase K, Corbetta B, Corbelli A, Fiordaliso F, Bruno S, Biancone L, Barreca A, Papotti MG, Hirsh E, Martini M, Gambino R, Durazzo M, Ohno H, Gruden G.
    Autophagy; 2023 Feb; 19(2):505-524. PubMed ID: 35659195
    [Abstract] [Full Text] [Related]

  • 34. Xanthine oxidoreductase inhibitor topiroxostat ameliorates podocyte injury by inhibiting the reduction of nephrin and podoplanin.
    Zhang Y, Fukusumi Y, Kayaba M, Nakamura T, Sakamoto R, Ashizawa N, Kawachi H.
    Nefrologia (Engl Ed); 2021 Feb; 41(5):539-547. PubMed ID: 36165136
    [Abstract] [Full Text] [Related]

  • 35. Emerging role of podocyte autophagy in the progression of diabetic nephropathy.
    Yasuda-Yamahara M, Kume S, Tagawa A, Maegawa H, Uzu T.
    Autophagy; 2015 Feb; 11(12):2385-6. PubMed ID: 26565953
    [Abstract] [Full Text] [Related]

  • 36. Inhibition of high mobility group box 1 (HMGB1) attenuates podocyte apoptosis and epithelial-mesenchymal transition by regulating autophagy flux.
    Jin J, Gong J, Zhao L, Zhang H, He Q, Jiang X.
    J Diabetes; 2019 Oct; 11(10):826-836. PubMed ID: 30864227
    [Abstract] [Full Text] [Related]

  • 37. Inhibition of NLRP3 inflammasome ameliorates podocyte damage by suppressing lipid accumulation in diabetic nephropathy.
    Wu M, Yang Z, Zhang C, Shi Y, Han W, Song S, Mu L, Du C, Shi Y.
    Metabolism; 2021 May; 118():154748. PubMed ID: 33675822
    [Abstract] [Full Text] [Related]

  • 38. KCa3.1 mediates dysfunction of tubular autophagy in diabetic kidneys via PI3k/Akt/mTOR signaling pathways.
    Huang C, Lin MZ, Cheng D, Braet F, Pollock CA, Chen XM.
    Sci Rep; 2016 Mar 31; 6():23884. PubMed ID: 27029904
    [Abstract] [Full Text] [Related]

  • 39. Xuesaitong Protects Podocytes from Apoptosis in Diabetic Rats through Modulating PTEN-PDK1-Akt-mTOR Pathway.
    Xue R, Zhai R, Xie L, Zheng Z, Jian G, Chen T, Su J, Gao C, Wang N, Yang X, Xu Y, Gui D.
    J Diabetes Res; 2020 Mar 31; 2020():9309768. PubMed ID: 32051833
    [Abstract] [Full Text] [Related]

  • 40. FNDC5/Irisin attenuates diabetic cardiomyopathy in a type 2 diabetes mouse model by activation of integrin αV/β5-AKT signaling and reduction of oxidative/nitrosative stress.
    Lin C, Guo Y, Xia Y, Li C, Xu X, Qi T, Zhang F, Fan M, Hu G, Zhao H, Zhao H, Liu R, Gao E, Yan W, Tao L.
    J Mol Cell Cardiol; 2021 Nov 31; 160():27-41. PubMed ID: 34224725
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.